loader
Please Wait
Applying Filters...

Renejix CDMO Partner for Small Molecule Oral Dosage Forms Renejix CDMO Partner for Small Molecule Oral Dosage Forms

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Aliskiren Fumarate, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Aliskiren Fumarate

    APIs // Active Pharmaceutical Ingredients

    DOSSIERs // Finished Dosage Forms

    PharmaCompass

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    2D Structure
    1. Also known as: Aliskiren (fumarate), 1196835-68-3, 173334-58-2, Aliskirenfumarate, (2e)-but-2-enedioic acid; bis((2s,4s,5s,7s)-5-amino-n-(2-carbamoyl-2,2-dimethylethyl)-4-hydroxy-7-{[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl}-8-methyl-2-(propan-2-yl)nonanamide), 5-amino-n-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methylnonanamide fumarate
    Molecular Formula
    C34H57N3O10
    Molecular Weight
    667.8  g/mol
    InChI Key
    RSFGNDXWVZPKJA-KVBHIGNWSA-N
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-2-propan-2-ylnonanamide;(E)-but-2-enedioic acid
    2.1.2 InChI
    InChI=1S/C30H53N3O6.C4H4O4/c1-19(2)22(14-21-10-11-26(38-8)27(15-21)39-13-9-12-37-7)16-24(31)25(34)17-23(20(3)4)28(35)33-18-30(5,6)29(32)36;5-3(6)1-2-4(7)8/h10-11,15,19-20,22-25,34H,9,12-14,16-18,31H2,1-8H3,(H2,32,36)(H,33,35);1-2H,(H,5,6)(H,7,8)/b;2-1+/t22-,23-,24-,25-;/m0./s1
    2.1.3 InChI Key
    RSFGNDXWVZPKJA-KVBHIGNWSA-N
    2.1.4 Canonical SMILES
    CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N.C(=CC(=O)O)C(=O)O
    2.1.5 Isomeric SMILES
    CC(C)[C@@H](CC1=CC(=C(C=C1)OC)OCCCOC)C[C@@H]([C@H](C[C@@H](C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N.C(=C/C(=O)O)\C(=O)O
    2.2 Synonyms
    2.2.1 Depositor-Supplied Synonyms

    1. Aliskiren (fumarate)

    2. 1196835-68-3

    3. 173334-58-2

    4. Aliskirenfumarate

    5. (2e)-but-2-enedioic Acid; Bis((2s,4s,5s,7s)-5-amino-n-(2-carbamoyl-2,2-dimethylethyl)-4-hydroxy-7-{[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl}-8-methyl-2-(propan-2-yl)nonanamide)

    6. 5-amino-n-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methylnonanamide Fumarate

    7. Chembl1667

    8. Mls006010401

    9. Hms3264i19

    10. Pharmakon1600-01505710

    11. Hy-12176b

    12. Mfcd27756642

    13. Nsc759185

    14. Akos025149418

    15. Akos037643745

    16. Ccg-213555

    17. Aliskiren Hemifumarate, >=95% (hplc)

    18. As-35076

    19. Smr004701404

    20. Cs-0134304

    21. Sr-05000001949

    22. Sr-05000001949-1

    23. Benzeneoctanamide, Delta-amino-n-(3-amino-2,2-dimethyl-3-oxopropyl)-gamma-hydroxy-4-methoxy-3-(3-methoxypropoxy)-alpha,zeta-bis(1-methylethyl)-, (alphas,gammas,deltas,zetas)-, (2e)-2-butenedioate (2:1)

    2.3 Create Date
    2006-10-25
    3 Chemical and Physical Properties
    Molecular Weight 667.8 g/mol
    Molecular Formula C34H57N3O10
    Hydrogen Bond Donor Count6
    Hydrogen Bond Acceptor Count11
    Rotatable Bond Count21
    Exact Mass667.40439502 g/mol
    Monoisotopic Mass667.40439502 g/mol
    Topological Polar Surface Area221 Ų
    Heavy Atom Count47
    Formal Charge0
    Complexity836
    Isotope Atom Count0
    Defined Atom Stereocenter Count4
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count1
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    Post Enquiry
    POST ENQUIRY